TRANSETHOSOMES: A NOVEL CARRIER FOR TRANSCUTANEOUS DRUG DELIVERY AN OVERVIEW

In recent years, the transdermal route has emerged as the most advantageous method for medication administration. It overcame several problems associated with the oral mode of drug administration, including significant issues with previous metabolism. To get around this restriction, transdermic administration systems have been created; however, the medications that can be administered via this route still encounter challenges since some of the drugs’ particles are ineffective at efficiently penetrating the stratum corneum. Our scientists and researchers have created a novel technology called as the extremely deformable vesicle system to meet this difficulty. The medicinal molecule, whether synthetic or natural, is combined with vesicles in this method so that it may be delivered to specific areas of the skin. Transethosomes are a unique promise for improved transdermal medication administration via the skin among transferosomes and ethosomes. Nanotransethosomes’ efficient penetration is facilitated by ethanol, edge activator, and phospholipids. The UDV can be used to administer a variety of medication classes via the transdermal route, including anti-arthritic, antibacterial, anticancer, antiviral and analgesic.